Literature DB >> 16204311

Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway.

Wei Zhao1, Claire Kitidis, Mark D Fleming, Harvey F Lodish, Saghi Ghaffari.   

Abstract

Erythropoietin (Epo) stimulation of its receptor's downstream signaling pathways and optimum function of GATA-1 transcription factor are both essential for normal erythroid cell development. Epo-receptor (EpoR) signaling and GATA-1 regulate proliferation, survival, differentiation, and maturation of erythroid cells. Whether any signal that is generated by EpoR targets GATA-1 or affects GATA-1 transcriptional activity is not known. Here, we demonstrate that stimulation of EpoR results in phosphorylation of GATA-1 at serine 310 (S310) in primary fetal liver erythroid progenitors and in cultured erythroid cells. We show that phosphorylation of GATA-1 is important for Epo-induced maturation of fetal liver erythroid progenitor cells. The PI3-kinase/AKT signaling pathway is identified as a mediator of Epo-induced phosphorylation of GATA-1. AKT serine threonine kinase phosphorylates GATA-1S310 in vitro and in erythroid cells and enhances GATA-1 transcriptional activity. These data demonstrate that EpoR signaling phosphorylates GATA-1 and modulates its activity via the PI3-kinase/AKT signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16204311      PMCID: PMC1895894          DOI: 10.1182/blood-2005-06-2516

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  70 in total

1.  Erythroid cells rendered erythropoietin independent by infection with Friend spleen focus-forming virus show constitutive activation of phosphatidylinositol 3-kinase and Akt kinase: involvement of insulin receptor substrate-related adapter proteins.

Authors:  K Nishigaki; C Hanson; T Ohashi; D Thompson; K Muszynski; S Ruscetti
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  An intrinsic but cell-nonautonomous defect in GATA-1-overexpressing mouse erythroid cells.

Authors:  D Whyatt; F Lindeboom; A Karis; R Ferreira; E Milot; R Hendriks; M de Bruijn; A Langeveld; J Gribnau; F Grosveld; S Philipsen
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

3.  AKT induces erythroid-cell maturation of JAK2-deficient fetal liver progenitor cells and is required for Epo regulation of erythroid-cell differentiation.

Authors:  Saghi Ghaffari; Claire Kitidis; Wei Zhao; Dragan Marinkovic; Mark D Fleming; Biao Luo; Joseph Marszalek; Harvey F Lodish
Journal:  Blood       Date:  2005-10-27       Impact factor: 22.113

4.  A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.

Authors:  Chloé James; Valérie Ugo; Jean-Pierre Le Couédic; Judith Staerk; François Delhommeau; Catherine Lacout; Loïc Garçon; Hana Raslova; Roland Berger; Annelise Bennaceur-Griscelli; Jean Luc Villeval; Stefan N Constantinescu; Nicole Casadevall; William Vainchenker
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

5.  Identification of an acquired JAK2 mutation in polycythemia vera.

Authors:  Runxiang Zhao; Shu Xing; Zhe Li; Xueqi Fu; Qingshan Li; Sanford B Krantz; Zhizhuang Joe Zhao
Journal:  J Biol Chem       Date:  2005-04-29       Impact factor: 5.157

6.  A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction.

Authors:  Y Kashii; M Uchida; K Kirito; M Tanaka; K Nishijima; M Toshima; T Ando; K Koizumi; T Endoh; K Sawada; M Momoi; Y Miura; K Ozawa; N Komatsu
Journal:  Blood       Date:  2000-08-01       Impact factor: 22.113

7.  Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors.

Authors:  S Uddin; S Kottegoda; D Stigger; L C Platanias; A Wickrema
Journal:  Biochem Biophys Res Commun       Date:  2000-08-18       Impact factor: 3.575

8.  A gain-of-function mutation of JAK2 in myeloproliferative disorders.

Authors:  Robert Kralovics; Francesco Passamonti; Andreas S Buser; Soon-Siong Teo; Ralph Tiedt; Jakob R Passweg; Andre Tichelli; Mario Cazzola; Radek C Skoda
Journal:  N Engl J Med       Date:  2005-04-28       Impact factor: 91.245

9.  Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival.

Authors:  Peter S Hammerman; Casey J Fox; Morris J Birnbaum; Craig B Thompson
Journal:  Blood       Date:  2005-02-10       Impact factor: 22.113

10.  CREB is a regulatory target for the protein kinase Akt/PKB.

Authors:  K Du; M Montminy
Journal:  J Biol Chem       Date:  1998-12-04       Impact factor: 5.157

View more
  76 in total

1.  Foxo3 is required for the regulation of oxidative stress in erythropoiesis.

Authors:  Dragan Marinkovic; Xin Zhang; Safak Yalcin; Julia P Luciano; Carlo Brugnara; Tara Huber; Saghi Ghaffari
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

2.  Phosphorylation of Gata1 at serine residues 72, 142, and 310 is not essential for hematopoiesis in vivo.

Authors:  Heather M Rooke; Stuart H Orkin
Journal:  Blood       Date:  2006-01-03       Impact factor: 22.113

3.  ARR19 (androgen receptor corepressor of 19 kDa), an antisteroidogenic factor, is regulated by GATA-1 in testicular Leydig cells.

Authors:  Imteyaz Qamar; Eunsook Park; Eun-Yeung Gong; Hyun Joo Lee; Keesook Lee
Journal:  J Biol Chem       Date:  2009-04-27       Impact factor: 5.157

Review 4.  Common themes emerge in the transcriptional control of T helper and developmental cell fate decisions regulated by the T-box, GATA and ROR families.

Authors:  Sara A Miller; Amy S Weinmann
Journal:  Immunology       Date:  2009-03       Impact factor: 7.397

Review 5.  Transcriptional mechanisms underlying hemoglobin synthesis.

Authors:  Koichi R Katsumura; Andrew W DeVilbiss; Nathaniel J Pope; Kirby D Johnson; Emery H Bresnick
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

Review 6.  Iron metabolism under conditions of ineffective erythropoiesis in β-thalassemia.

Authors:  Stefano Rivella
Journal:  Blood       Date:  2018-11-06       Impact factor: 22.113

7.  Single-cell analyses demonstrate that a heme-GATA1 feedback loop regulates red cell differentiation.

Authors:  Raymond T Doty; Xiaowei Yan; Christopher Lausted; Adam D Munday; Zhantao Yang; Danielle Yi; Neda Jabbari; Li Liu; Siobán B Keel; Qiang Tian; Janis L Abkowitz
Journal:  Blood       Date:  2018-12-10       Impact factor: 22.113

Review 8.  Systems approaches to preventing transplanted cell death in cardiac repair.

Authors:  Thomas E Robey; Mark K Saiget; Hans Reinecke; Charles E Murry
Journal:  J Mol Cell Cardiol       Date:  2008-03-19       Impact factor: 5.000

9.  Hematopoiesis and RAS-driven myeloid leukemia differentially require PI3K isoform p110α.

Authors:  Kira Gritsman; Haluk Yuzugullu; Thanh Von; Howard Yan; Linda Clayton; Christine Fritsch; Sauveur-Michel Maira; Gregory Hollingworth; Christine Choi; Tulasi Khandan; Mahnaz Paktinat; Rachel O Okabe; Thomas M Roberts; Jean J Zhao
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

10.  SENP1-mediated GATA1 deSUMOylation is critical for definitive erythropoiesis.

Authors:  Luyang Yu; Weidong Ji; Haifeng Zhang; Matthew J Renda; Yun He; Sharon Lin; Ee-chun Cheng; Hong Chen; Diane S Krause; Wang Min
Journal:  J Exp Med       Date:  2010-05-10       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.